{"id":12325,"date":"2026-11-01T15:10:53","date_gmt":"2026-11-01T15:10:53","guid":{"rendered":"https:\/\/www.musclestationth.com\/?p=12325"},"modified":"2026-11-01T15:10:53","modified_gmt":"2026-11-01T15:10:53","slug":"enclomiphene-evidence-safety-guide","status":"publish","type":"post","link":"https:\/\/www.musclestationth.com\/en\/enclomiphene-evidence-safety-guide\/","title":{"rendered":"Enclomiphene: Hormone Results Are Not a Promise of Clinical Benefit"},"content":{"rendered":"<p>Understand enclomiphene research in selected men with low testosterone, distinguish biomarkers from clinical benefit, and read ENCLOMID 25 labeling cautiously.<\/p><p>Enclomiphene is a SERM and the trans-isomer of clomiphene. Research in selected men with hypogonadism does not establish the efficacy or quality of the pictured SA ENCLOMID 25 product. <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/enclomiphene-citrate\" rel=\"noopener\">[E1]<\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26496621\/\" rel=\"noopener\">[E2]<\/a><\/p><section aria-labelledby=\"identity\"><h2 id=\"identity\">1. Separate substance names from product labels<\/h2><p>Enclomiphene identifies a substance; ENCLOMID 25 identifies wording on the supplied image. Its relationship to clomiphene does not establish universal interchangeability. A SERM mechanism is not proof of every proposed benefit. <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/enclomiphene-citrate\" rel=\"noopener\">[E1]<\/a><\/p><\/section><figure class=\"msth-informational-figure\"><img class=\"wp-image-12317\" src=\"https:\/\/www.musclestationth.com\/wp-content\/uploads\/2026\/11\/sa-enclomiphene-enclomid-25-label.jpg\" alt=\"SA Anabolic ENCLOMID 25 bottle labelled Enclomiphene Citrate USP 25 mg\" width=\"1445\" height=\"1536\" loading=\"lazy\" decoding=\"async\" style=\"display:block;max-width:100%;height:auto\"><figcaption>User-supplied label illustration. It does not verify contents, quality, registration or treatment outcomes; the number is not dosing advice.<\/figcaption><\/figure><section aria-labelledby=\"evidence\"><h2 id=\"evidence\">2. What the human studies measured<\/h2><p>Two phase 3 studies followed overweight men aged 18\u201360 with secondary hypogonadism for 16 weeks. Testosterone\/LH\/FSH increased and sperm concentration was maintained during the study. These endpoints do not establish pregnancy, live birth or training benefits. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26496621\/\" rel=\"noopener\">[E2]<\/a><\/p><p>Earlier phase 2 research also assessed hormonal and semen outcomes. These measurements should not be relabeled as guaranteed fertility or symptom improvement. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25044085\/\" rel=\"noopener\">[E4]<\/a><\/p><div class=\"table-wrap\" tabindex=\"0\" role=\"region\" aria-label=\"Evidence table\" style=\"overflow-x:auto;max-width:100%\"><table><thead><tr><th scope=\"col\">Question<\/th><th scope=\"col\">Evidence<\/th><th scope=\"col\">Finding<\/th><th scope=\"col\">Limitation<\/th><\/tr><\/thead><tbody><tr><td>Hormone changes<\/td><td>Randomized studies in selected men<\/td><td>Hormonal changes observed<\/td><td>Not every population or symptom<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26496621\/\" rel=\"noopener\">[E2]<\/a><\/td><\/tr><tr><td>Fertility\/long-term outcomes<\/td><td>Reviewed studies focus on hormones\/semen<\/td><td>Not established here<\/td><td>Sperm counts are not pregnancy\/live birth<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25044085\/\" rel=\"noopener\">[E4]<\/a><\/td><\/tr><tr><td>ENCLOMID 25 quality<\/td><td>Label image<\/td><td>NOT VERIFIED<\/td><td>No bottle\/batch-specific proof<\/td><\/tr><\/tbody><\/table><\/div><\/section><section aria-labelledby=\"clinical-regulatory\"><h2 id=\"clinical-regulatory\">3. Clinical benefit and regulatory context<\/h2><p>EMA&#39;s EnCyzix assessment identified missing symptom-benefit evidence despite hormone changes, alongside venous-thromboembolism concerns. EU marketing authorization was refused on 6 April 2018. This is a dated, product-specific decision, not a complete current worldwide registration assessment. <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/encyzix\" rel=\"noopener\">[E3]<\/a><\/p><\/section><section aria-labelledby=\"label-image\"><h2 id=\"label-image\">4. An illustration, not product certification<\/h2><p>The image displays SA Anabolic, ENCLOMID 25, Enclomiphene Citrate USP and 25 mg. It does not establish contents, potency, purity, authenticity or Thai registration. Printed USP wording is not a batch test.<\/p><p>This page supplies no dose, regimen, post-cycle protocol, price, purchase button or brand endorsement. Symptoms and treatment options require individual clinical assessment.<\/p><\/section><section><h2>Frequently asked questions<\/h2><h3>Is enclomiphene testosterone?<\/h3><p>No. It is a SERM related to clomiphene, not testosterone itself. <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/enclomiphene-citrate\" rel=\"noopener\">[E1]<\/a><\/p><h3>Do improved hormone results guarantee symptom improvement?<\/h3><p>No. Clinical benefit needs separate evidence; EMA highlighted that gap for EnCyzix. <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/encyzix\" rel=\"noopener\">[E3]<\/a><\/p><h3>Do these studies prove improved fertility?<\/h3><p>The reviewed endpoints concern hormones and semen, not demonstrated pregnancy or live-birth benefit. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25044085\/\" rel=\"noopener\">[E4]<\/a><\/p><h3>Are 25 mg and USP a recommendation or certification?<\/h3><p>No. They are visible label statements, not verified contents, quality or suitability for an individual.<\/p><\/section><section><h2>Sources<\/h2><ol><li id=\"source-E1\"><a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/enclomiphene-citrate\" rel=\"noopener\">[E1] NCI Drug Dictionary: enclomiphene citrate<\/a><\/li><li id=\"source-E2\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26496621\/\" rel=\"noopener\">[E2] Kim et al. Enclomiphene and testosterone\/sperm outcomes; online 2015, BJU International 2016<\/a><\/li><li id=\"source-E3\"><a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/encyzix\" rel=\"noopener\">[E3] EMA: EnCyzix assessment and refusal of marketing authorization<\/a><\/li><li id=\"source-E4\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25044085\/\" rel=\"noopener\">[E4] Wiehle et al. Randomized phase 2 enclomiphene trial, 2014<\/a><\/li><\/ol><\/section><p>Educational evidence context, not prescribing advice or product endorsement. Sources reviewed on 1 November 2026.<\/p>","protected":false},"excerpt":{"rendered":"<p>Understand enclomiphene research in selected men with low testosterone, distinguish biomarkers from clinical benefit, and read ENCLOMID 25 labeling cautiously.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_seo_schema_type":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[281],"tags":[],"class_list":["post-12325","post","type-post","status-publish","format-standard","hentry","category-281"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"admin","author_link":"https:\/\/www.musclestationth.com\/en\/author\/musclestationth\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.musclestationth.com\/en\/category\/%e0%b8%9a%e0%b8%97%e0%b8%84%e0%b8%a7%e0%b8%b2%e0%b8%a1%e0%b8%97%e0%b8%b5%e0%b9%88%e0%b8%99%e0%b9%88%e0%b8%b2%e0%b8%aa%e0%b8%99%e0%b9%83%e0%b8%88\/\" rel=\"category tag\">\u0e1a\u0e17\u0e04\u0e27\u0e32\u0e21\u0e17\u0e35\u0e48\u0e19\u0e48\u0e32\u0e2a\u0e19\u0e43\u0e08<\/a>","rttpg_excerpt":"Enclomiphene \u0e40\u0e1b\u0e47\u0e19\u0e2a\u0e32\u0e23\u0e01\u0e25\u0e38\u0e48\u0e21 SERM \u0e41\u0e25\u0e30\u0e40\u0e1b\u0e47\u0e19 trans-isomer \u0e02\u0e2d\u0e07 clomiphene \u0e21\u0e35\u0e07\u0e32\u0e19\u0e27\u0e34\u0e08\u0e31\u0e22\u0e43\u0e19\u0e1c\u0e39\u0e49\u0e0a\u0e32\u0e22\u0e1a\u0e32\u0e07\u0e01\u0e25\u0e38\u0e48\u0e21\u0e17\u0e35\u0e48\u0e21\u0e35\u0e20\u0e32\u0e27\u0e30\u0e2e\u0e2d\u0e23\u0e4c\u0e42\u0e21\u0e19\u0e15\u0e48\u0e33 \u0e41\u0e15\u0e48\u0e2b\u0e25\u0e31\u0e01\u0e10\u0e32\u0e19\u0e14\u0e31\u0e07\u0e01\u0e25\u0e48\u0e32\u0e27\u0e44\u0e21\u0e48\u0e22\u0e37\u0e19\u0e22\u0e31\u0e19\u0e1b\u0e23\u0e30\u0e2a\u0e34\u0e17\u0e18\u0e34\u0e20\u0e32\u0e1e\u0e2b\u0e23\u0e37\u0e2d\u0e04\u0e38\u0e13\u0e20\u0e32\u0e1e\u0e02\u0e2d\u0e07 ENCLOMID 25 \u0e22\u0e35\u0e48\u0e2b\u0e49\u0e2d SA \u0e43\u0e19\u0e20\u0e32\u0e1e [E1][E2] 1. \u0e41\u0e22\u0e01\u0e0a\u0e37\u0e48\u0e2d\u0e2a\u0e32\u0e23 \u0e0a\u0e37\u0e48\u0e2d\u0e22\u0e32 \u0e41\u0e25\u0e30\u0e0a\u0e37\u0e48\u0e2d\u0e1a\u0e19\u0e09\u0e25\u0e32\u0e01 \u0e04\u0e33\u0e27\u0e48\u0e32 enclomiphene \u0e23\u0e30\u0e1a\u0e38\u0e2a\u0e32\u0e23 \u0e2a\u0e48\u0e27\u0e19 ENCLOMID 25 \u0e40\u0e1b\u0e47\u0e19\u0e02\u0e49\u0e2d\u0e04\u0e27\u0e32\u0e21\u0e0a\u0e37\u0e48\u0e2d\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e43\u0e19\u0e20\u0e32\u0e1e \u0e04\u0e27\u0e32\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e02\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e1a clomiphene \u0e44\u0e21\u0e48\u0e44\u0e14\u0e49\u0e41\u0e1b\u0e25\u0e27\u0e48\u0e32\u0e22\u0e32\u0e17\u0e31\u0e49\u0e07\u0e2a\u0e2d\u0e07\u0e21\u0e35\u0e2a\u0e39\u0e15\u0e23\u0e2b\u0e23\u0e37\u0e2d\u0e43\u0e0a\u0e49\u0e41\u0e17\u0e19\u0e01\u0e31\u0e19\u0e44\u0e14\u0e49\u0e17\u0e38\u0e01\u0e01\u0e23\u0e13\u0e35 \u0e41\u0e25\u0e30\u0e19\u0e34\u0e22\u0e32\u0e21\u0e01\u0e25\u0e44\u0e01\u0e02\u0e2d\u0e07 SERM \u0e44\u0e21\u0e48\u0e43\u0e0a\u0e48\u0e2b\u0e25\u0e31\u0e01\u0e10\u0e32\u0e19\u0e22\u0e37\u0e19\u0e22\u0e31\u0e19\u0e1b\u0e23\u0e30\u0e42\u0e22\u0e0a\u0e19\u0e4c\u0e17\u0e38\u0e01\u0e14\u0e49\u0e32\u0e19 [E1] 2. \u0e07\u0e32\u0e19\u0e27\u0e34\u0e08\u0e31\u0e22\u0e43\u0e19\u0e04\u0e19\u0e27\u0e31\u0e14\u0e2d\u0e30\u0e44\u0e23 \u0e01\u0e32\u0e23\u0e28\u0e36\u0e01\u0e29\u0e32\u0e23\u0e30\u0e22\u0e30 3 \u0e2a\u0e2d\u0e07\u0e0a\u0e38\u0e14\u0e43\u0e19\u0e1c\u0e39\u0e49\u0e0a\u0e32\u0e22\u0e2d\u0e32\u0e22\u0e38 18\u201360 \u0e1b\u0e35\u0e17\u0e35\u0e48\u0e21\u0e35\u0e19\u0e49\u0e33\u0e2b\u0e19\u0e31\u0e01\u0e40\u0e01\u0e34\u0e19\u0e41\u0e25\u0e30 secondary hypogonadism \u0e15\u0e34\u0e14\u0e15\u0e32\u0e21 16 \u0e2a\u0e31\u0e1b\u0e14\u0e32\u0e2b\u0e4c \u0e1e\u0e1a\u0e01\u0e32\u0e23\u0e40\u0e1e\u0e34\u0e48\u0e21 testosterone\/LH\/FSH \u0e41\u0e25\u0e30\u0e01\u0e32\u0e23\u0e04\u0e07\u0e04\u0e27\u0e32\u0e21\u0e40\u0e02\u0e49\u0e21\u0e02\u0e49\u0e19\u0e2d\u0e2a\u0e38\u0e08\u0e34\u0e23\u0e30\u0e2b\u0e27\u0e48\u0e32\u0e07\u0e01\u0e32\u0e23\u0e28\u0e36\u0e01\u0e29\u0e32 \u0e1c\u0e25\u0e40\u0e2b\u0e25\u0e48\u0e32\u0e19\u0e35\u0e49\u0e44\u0e21\u0e48\u0e43\u0e0a\u0e48\u0e01\u0e32\u0e23\u0e1e\u0e34\u0e2a\u0e39\u0e08\u0e19\u0e4c\u0e42\u0e2d\u0e01\u0e32\u0e2a\u0e15\u0e31\u0e49\u0e07\u0e04\u0e23\u0e23\u0e20\u0e4c \u0e01\u0e32\u0e23\u0e04\u0e25\u0e2d\u0e14\u0e21\u0e35\u0e0a\u0e35\u0e1e \u0e2b\u0e23\u0e37\u0e2d\u0e41\u0e23\u0e07\u0e1d\u0e36\u0e01 [E2] \u0e01\u0e32\u0e23\u0e28\u0e36\u0e01\u0e29\u0e32\u0e23\u0e30\u0e22\u0e30 2 \u0e01\u0e48\u0e2d\u0e19\u0e2b\u0e19\u0e49\u0e32\u0e43\u0e2b\u0e49\u0e02\u0e49\u0e2d\u0e21\u0e39\u0e25\u0e14\u0e49\u0e32\u0e19\u0e2e\u0e2d\u0e23\u0e4c\u0e42\u0e21\u0e19\u0e41\u0e25\u0e30\u0e19\u0e49\u0e33\u0e40\u0e0a\u0e37\u0e49\u0e2d\u0e40\u0e0a\u0e48\u0e19\u0e01\u0e31\u0e19&hellip;","_links":{"self":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts\/12325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/comments?post=12325"}],"version-history":[{"count":1,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts\/12325\/revisions"}],"predecessor-version":[{"id":12326,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts\/12325\/revisions\/12326"}],"wp:attachment":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/media?parent=12325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/categories?post=12325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/tags?post=12325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}